Abstract:Melanoma is a malignant tumor with the highest growth dynamics in terms of the number of cases, simultaneously being the main cause of cancer-related deaths due to skin malignancies. [ 1 , 2 ] The incidence of melanoma is 10 to 25 new cases per 100,000 inhabitants; in the United States of America, it is 20 to 30 per 100,000; and in Australia, where a very high incidence is observed, it reaches 50 to 60 per 100,000. In recent years, there has been a dramatic increase in melanoma incidence among individuals over 60 years of age, especially in men. It is predicted that this upward trend will persist for the coming decades. [ 3 ] Melanoma cases in Poland are fewer than half of the European Union average. Nevertheless, despite the lower number of cases, Poland has one of the highest mortality rates in relation to incidence in Europe and reports more deaths due to melanoma. [ 4 ] Moreover, in Poland, around 1500 melanomas are detected each year at an advanced or metastatic stage. The most common phenotypic risk factor for melanoma is fair skin with a tendency to sunburn. Greater risk of developing this type of cancer also exists among individuals with a high number of pigmented lesions and large congenital and dysplastic nevi. Conversely, the most important exogenous factor is exposure to ultraviolet radiation. [ 5 ] Melanoma incidence also has a genetic basis, most commonly associated with familial atypical multiple mole melanoma syndrome. In this syndrome, mutations in the cyclin-dependent kinase inhibitor 2A gene, and less frequently in cyclin-dependent kinase 4 (CDK4), are often observed. Overall, up to 45% of genetically-caused melanomas are linked to known germline mutations in the cyclin-dependent kinase inhibitor 2A or CDK4 genes. [ 6 , 7 ] Furthermore, it has been shown that excessive exposure to ultraviolet radiation influences the genetic characteristics of melanomas. The mutation of the B-Raf protein gene in which valine (V) is substituted by glutamic acid (E) at amino acid 600 genotype is more common in patients who used tanning beds compared to those who never did, and it is also more prevalent in patients who started tanning before the age of 25 compared to those who started later in life. [ 8 ] Among Poles, fair skin complexion is predominant, significantly increasing the risk of melanoma development. Intensive preventive efforts can contribute to identifying this cancer in earlier stages of its progression, consequently leading to a reduction in melanoma-related deaths. Among preventive measures aimed at early melanoma detection, clinical examinations conducted by dermatologists and enhanced with dermoscopy are particularly important due to their widespread accessibility and effectiveness. Clinical diagnosis of melanoma is based on: visual examination of the entire body's skin, utilizing the ABCDE criteria (asymmetry, irregular border, uneven color, diameter > 6 mm, and evolution over time) to detect suspicious oncological pigmented lesions; a comparative analysis involving the search for a change that does not resemble others in the same patient and evaluating the development of pathological pigmented lesions based on available documentation. The sensitivity of clinical diagnosis performed by experienced dermatologists is estimated at around 70%. [ 9 ] Expanding the clinical examination with dermoscopy increases the accuracy of assessment, achieving a sensitivity of 89% and specificity of 79% in melanoma detection. [ 10 ] Dermoscopy should encompass all nevi, not just clinically suspicious ones, as it potentially allows for the detection of melanoma's morphological features before it becomes clinically recognizable. Numerous observational studies have shown that regular whole-body screening examinations conducted by physicians are associated with a decreased frequency of advanced-stage melanomas and reduced mortality due to them. [ 11–13 ] The aim of this study was to assess the prevalence of melanoma risk factors among residents of the Silesian Voivodeship and their knowledge regarding the diagnosis and prevention of this mentioned cancer.

Nevi and Melanoma in Children: What to Do in Daily Medical Practice: Encyclopedia for Pediatricians and Family Doctors

Nevi - when to refer

Epidemiological characteristics and hospitalization burden analysis of pediatric inpatients with melanocytic nevi in China from 2016 to 2021: A nationwide retrospective study of 13,396 cases

Clinical and Dermoscopic Insights Into Scalp Nevi in Chinese Children

Melanoma on congenital melanocytic nevi

Neonatal cutaneous melanoma with cutaneous metastasis: a case report and review of literature

A clinical and biologic review of congenital melanocytic nevi

Updates in the Management of Congenital Melanocytic Nevi

Proliferative nodules in congenital melanocytic nevi: a clinicopathologic and immunohistochemical analysis

Melanoma in Pediatric and Young Adult Patients

Application of dermoscopy and reflectance confocal microscopy in vivo in the evaluation of nevi in children

[Proliferative Nodules in Congenital Melanocytic Nevi: a Clinicopathological Analysis of Eight Cases].

Prevalence, incidence density and standardized morbidity rate of melanoma among patients with congenital melanocytic nevi: A systematic review

Nevi, dysplastic nevi, and melanoma: Molecular and immune mechanisms involving the progression

Melanoma arising in a child with a medium-sized congenital melanocytic nevus

A Clinicopathological Analysis of Melanocytic Nevi: A Retrospective Series

Giant Congenital Melanocytic Nevi in Neonates: Report of Two Cases.

Melanoma‐like features in pediatric longitudinal melanonychia: A systematic review and meta‐analysis

Melanoma of the central nervous system based on neurocutaneous melanocytosis in childhood: A rare but fatal condition

Patchy Dermal Melanocytosis: Differential Diagnosis and Management

Prevention of cancer—Melanoma development and its diagnosis among Silesian Voivodeship residents: Preliminary results